[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342992-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342992-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","application-of-fusobacterium-nucleatum-as-a-biomarker-in-gastrointestinal-malignancies","Application of Fusobacterium nucleatum as a Biomarker in Gastrointestinal Malignancies","","Gastrointestinal malignancies rank among the highest in global morbidity and mortality, with insidious onset that limits early diagnosis and contributes to rapid progression, poor treatment response, and unfavorable prognosis. Fusobacterium nucleatum, a gram-negative sporefree anaerobic bacterium, colonizes the oral cavity and has been implicated in colorectal, esophageal, gastric, and pancreatic cancers through multiple mechanisms. Evidence indicates that measuring F. nucleatum abundance in stool, saliva, and serum may support diagnosis, risk stratification, and prognosis monitoring. This editorial summarizes biological roles and mechanisms and emphasizes clinical translation of F. nucleatum as a biomarker in GI malignancies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/application-of-fusobacterium-nucleatum-as-a-biomarker-in-gastrointestinal-malignancies/342992/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/application-of-fusobacterium-nucleatum-as-a-biomarker-in-gastrointestinal-malignancies/342992.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early diagnosis of gastrointestinal malignancies difficult and important?","Question",{"text":63,"@type":64},"Early-stage gastrointestinal cancers often lack specific symptoms, leading to delayed diagnosis. Delays contribute to progression to advanced disease, resulting in poor prognosis and survival outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is Fusobacterium nucleatum and how is it linked to gastrointestinal cancers?",{"text":68,"@type":64},"Fusobacterium nucleatum is a gram-negative sporefree anaerobic bacterium that primarily colonizes the oral cavity. It has been implicated in the development of colorectal, esophageal, gastric, and pancreatic cancers via multiple mechanisms.",{"name":70,"@type":61,"acceptedAnswer":71},"How can Fusobacterium nucleatum be used as a biomarker in GI malignancies?",{"text":72,"@type":64},"Detecting F. nucleatum abundance in stool, saliva, and serum may aid diagnosis, risk assessment, and monitoring of prognosis in gastrointestinal malignancies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342992,1790476903,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","| W | J | G | O | World Journal of\u003Cbr>Gastrointestinal Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastrointest Oncol 2024 June 15; 16(6): 2271-2283  \nDOI: 10.4251/wjgo.v16.i6.2271 ISSN 1948-5204 (online)  \nEDITORIAL  \nApplication of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies  \nLong-Chen Yu, Ya-Ping Li, Yue-Ming Xin, Mai Mao, Ya-Xin Pan, Yi-Xuan Qu, Zheng-Dong Luo, Yi Zhang, Xin Zhang  \nSpecialty type: Oncology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade C  \nNovelty: Grade B  \nCreativity or Innovation: Grade B  \nScientific Significance: Grade B  \nP-Reviewer: Bubnov R, Ukraine  \nReceived: December 20, 2023  \nRevised: April 8, 2024  \nAccepted: April 28, 2024  \nPublished online: June 15, 2024  \nLong-Chen Yu, Ya-Ping Li, Yue-Ming Xin, Mai Mao, Ya-Xin Pan, Yi-Xuan Qu, Zheng-Dong Luo, Yi Zhang, Xin Zhang, Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan 250012, Shandong Province, China  \nCo-corresponding authors: Yi Zhang and Xin Zhang.  \nCorresponding author: Xin Zhang, MD, PhD, Additional Professor, Department of Clinical Laboratory, Qilu Hospital of Shandong University, Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, No. 107 Wenhua Xi Road, Jinan 250012, Shandong Province, [China.](China. xinzhang@sdu.edu.cn)[ xinzhang@sdu.edu.cn](China. xinzhang@sdu.edu.cn)  \nAbstract  \nThe morbidity and mortality of gastrointestinal (GI) malignancies are among the highest in the world, posing a serious threat to human health. Because of the insidious onset of the cancer, it is difficult for patients to be diagnosed at an early stage, and it rapidly progresses to an advanced stage, resulting in poor treatment and prognosis. Fusobacterium nucleatum (F. nucleatum) is a gram-negative, sporefree anaerobic bacterium that primarily colonizes the oral cavity and is implicated in the development of colorectal, esophageal, gastric, and pancreatic cancers via various intricate mechanisms. Recent development in novel research suggests that F. nucleatum may function as a biomarker in GI malignancies. Detecting the abundance of F. nucleatum in stool, saliva, and serum samples of patients may aid in the diagnosis, risk assessment, and prognosis monitoring of GI malignancies. This editorial systematically describes the biological roles and mechanisms of F. nucleatum in GI malignancies focusing on the application of F. nucleatum as abiomarker in the diagnosis and prognosis of GI malignancies to promote the clinical translation of F. nucleatum and GI tumors-related research.  \nKey Words: Gastrointestinal malignancies; Fusobacterium nucleatum ; Biomarker; Diagnosis; Prognosis  \n©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.  \n WJGO  [https://www.wjgnet.com](https://www.wjgnet.com) 2271 June 15, 2024  Volume 16  Issue 6   \nYu LC et al. Application of F. nucleatum as a biomarker  \nCore Tip: Gastrointestinal (GI) malignancies are characterized by high morbidity and mortality. Early diagnosis of GI malignancies is crucial for disease intervention and treatment. Numerous studies have shown that Fusobacterium nucleatum (F. nucleatum) is closely related to the development of various GI malignant tumors. This paper discusses the mechanism of F. nucleatum in promoting the progression of GI tumors, elaborates its clinical value as a diagnostic and prognostic biomarker, and provides ideas for the development and research of novel biomarkers for GI malignancies.  \nCitation: Yu LC, Li YP, Xin YM, Mao M, Pan YX, Qu YX, Luo ZD, Zhang Y, Zhang X. Application ofFusobacterium nucleatum asa biomarker in gastrointestinal malignancies. Wor","cbCaivtoJP63kAOu","https://ap.wps.com/l/cbCaivtoJP63kAOu","pdf",1491719,14,"English","# Editorial\n## Core Tip\n## Introduction","[{\"question\":\"Why is early diagnosis of gastrointestinal malignancies difficult and important?\",\"answer\":\"Early-stage gastrointestinal cancers often lack specific symptoms, leading to delayed diagnosis. Delays contribute to progression to advanced disease, resulting in poor prognosis and survival outcomes.\"},{\"question\":\"What is Fusobacterium nucleatum and how is it linked to gastrointestinal cancers?\",\"answer\":\"Fusobacterium nucleatum is a gram-negative sporefree anaerobic bacterium that primarily colonizes the oral cavity. It has been implicated in the development of colorectal, esophageal, gastric, and pancreatic cancers via multiple mechanisms.\"},{\"question\":\"How can Fusobacterium nucleatum be used as a biomarker in GI malignancies?\",\"answer\":\"Detecting F. nucleatum abundance in stool, saliva, and serum may aid diagnosis, risk assessment, and monitoring of prognosis in gastrointestinal malignancies.\"}]","Application of Fusobacterium nucleatum as a Biomarker in Gastrointestinal Malignancies | PDF",1790049299,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23f3aceb3a0549679d8157a629cac985.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c002cecea2893f130511e06c90f5898.webp",982,1389,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee98233cdc20bd7ec7ba6cfbbf2c3e80.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b11e6d077c023b986e3afdd494c9f33e.webp",980,1386]